nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.07.2004 | Letter to the Editor

¹⁸FDG imaging of giant cell arteritis: usefulness of whole-body plus brain PET

verfasst von: Tarik Belhocine

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 7/2004

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Weiner SM, Vaith P, Walker UA, Brink I. Detection of alterations in brain glucose metabolism by positron emission tomography in Takayasu’s arterities. Eur J Nucl Med Mol Imaging 2004; 31:300–302.CrossRef

Belhocine T, Blockmans D, Hustinx R, Vandevivere J, Mortelmans L. Imaging of large vessel vasculitis with¹⁸FDG PET: illusion or reality? A critical review of the literature. Eur J Nucl Med Mol Imaging 2003; 30:1305–1313.CrossRefPubMed

Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Benoit T, Foidart-Willems J. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996; 23:1641–1674.PubMed

Ludwig V, Komori T, Kolb D, Martin WH, Sandler M, Delbeke D. Cerebral lesions incidentally detected on 2-deoxy-2¹⁸Ffluoro-d-glucose positron emission tomography images of patients evaluated for body malignancies. Mol Imaging Biol 2002; 4:359–362.CrossRefPubMed

Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, Bobbaers H, Mortelmans L. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxf) 1999; 38:444–447.

Hara M, Goodman PC, Leder RA. FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr 1999; 23:16–18.PubMed

Ishii K. Clinical application of positron emission tomography for diagnosis of dementia. Ann Nucl Med 2002; 16:515–525.PubMed

Wildhagen K, Meyer GJ, Stoppe G, Heintz P, Deicher H, Hundeshagen H. PET and MR imaging in a neuro-Behçet syndrome. Eur J Nucl Med 1999; 15:764–766.

Weiner SM, Otte A, Schumacher M, Juengling FD, Brink I, Nitzsche EU, Peter HH, Kreisel W. Neuro-Behçet’s syndrome in a patient not fulfilling criteria for Behçet’s disease: clinical features and value of brain imaging. Clin Rheumatol 2000; 19:231–234.CrossRefPubMed

10.

Weiner SM, Otte A, Schumacher M, Brink I, Juengling FD, Sobanski T, Nitzsche EU, Peter HH. Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric lupus erythematosus. Lupus 2000; 9:386–389.PubMed

11.

Dubey N, Miletich RS, Wasay M, Mechtler LL, Bakshi R. Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis. J Neurol Sci 2002; 205:77–81.CrossRefPubMed

12.

Schirmer M, Calamia KT, Wenger M, Klauser A, Salvarani C, Moncayo R.¹⁸F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective. Exp Gerontol 2003; 38:463–470.CrossRefPubMed

13.

Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomography imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 2002; 32:47–59.PubMed

Titel: 18FDG imaging of giant cell arteritis: usefulness of whole-body plus brain PET
verfasst von: Tarik Belhocine
Publikationsdatum: 01.07.2004
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 7/2004
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-004-1547-4

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2004

CT-guided lymphoscintigraphy in patients with squamous cell carcinoma of the head and neck: a feasibility study

July 2004

Radionuclide therapy in oncology: the dawning of its concomitant use with other modalities?

Effects of partial volume correction on discrimination between very early Alzheimer’s dementia and controls using brain perfusion SPECT

Improving the quality of small animal brain pinhole SPECT imaging by Bayesian reconstruction

Peritoneal strumosis